Clinical knowledge, organized
Approved clinical knowledge is organized so specialists can review it and partners can understand its value, linked to its sources.
Inviting founding hospital and research partners · Saudi Arabia
HEALTHx
Turn your hospital’s clinical know-how into tested health innovation.
HEALTHx is a company founded by Prof. Adeeb Noor: a clinical innovation platform; invention disclosure under review. Hospital and research partners are invited to co-develop and evaluate the approach.
- Invention disclosure under review · King Abdulaziz University
- Active master’s research
- Founding partners invited
The core concept
A bridge from clinical knowledge to licensable assets.
The research concept connects three components. They describe the proposed development and evaluation scope, not a finished product.
Validation, privacy and governance
Evaluate quality, protect sensitive information, and establish usage rights and approval responsibilities before sharing an asset.
Licensing and market translation
Explore routes to licensing, research partnerships and co-development. Licensing and service revenue are hypotheses to test with partners.
Candidate assets include approved protocols, diagnostic algorithms, clinical methods and reusable research outputs, subject to rights and approvals. Not every asset is assumed to be patentable. Evaluation will examine preparation time, quality, privacy, usability and partner interest; outcomes are not promised before measurement.
Why HEALTHx
The knowledge that usual innovation routes miss.
Technology-transfer offices handle inventions; hospital innovation programmes collect ideas. The everyday expertise in protocols, diagnostic reasoning and workflows usually stays inside teams. HEALTHx focuses on exactly that knowledge.
| Aspect | Typical technology transfer | Typical hospital innovation programme | HEALTHx |
|---|---|---|---|
| What it captures | Patentable inventions | Staff ideas and start-ups | Know-how in protocols, diagnostic reasoning, workflows and research outputs |
| Starting point | An invention disclosure | An idea pitch | A documented clinical need with its knowledge context and sources |
| How it is assessed | Legal and market review | Business review | Clinical relevance, technical feasibility and IP together, with traceable sources |
| Role of AI | Usually none | Varies | Helps structure and explain knowledge, with human review at every step |
| Role of the hospital | Source of inventions | Programme host | Founding partner that chooses the problem and co-develops and evaluates the solution |
A general comparison with common models, not with named organizations. Novelty is assessed formally through the University’s IP review.
Founding hospital partner
A clinical partner. Shared development. Value that can scale.
We invite hospitals and health systems to discuss a co-development and commercialization partnership. Start with one agreed use case, then decide whether to scale on the strength of evidence and feasibility. Founding partners choose the first use case and help shape the method.
What HEALTHx proposes
Concept and research leadership, structured opportunity discovery, a knowledge-representation approach, and coordination of prototype development and evaluation.
What we seek from the hospital
An executive sponsor, a clinical lead, a priority problem, specialist time, and governance and evaluation support. Resources, funding and access are to be agreed jointly.
The proposed shared value
Test a solution to a real hospital need, build reusable knowledge and assets, and explore future revenue through licensing, services or a joint venture. These are commercial hypotheses to validate.
A proposed starting path
1. Discovery and need definition → 2. Agreement on scope, rights and evaluation → 3. Prototype and appropriately approved pilot → 4. Joint development and commercialization decision.
Background and newly developed IP, funding, licensing, revenue sharing or equity, and publication rights are to be negotiated after rights review and institutional approvals. No final terms or guaranteed returns are offered here. Agreements follow King Abdulaziz University’s IP and partnership procedures.
Start a partnership discussion ↗Research partnership
For research groups and universities, in Saudi Arabia and abroad.
What you bring
A research question in one of the five tracks, researchers or graduate students, and methodological expertise.
What you gain
Opportunities to propose hospital-based studies once a partner and approvals are secured, co-authored publications, theses and joint grant applications, with credit agreed up front.
How we start
A short introductory call, then a one-page research brief, then agreed roles, credit and IP before work begins.
01 / The vision
A national ambition, built through focused contributions.
Valuable knowledge lives in clinical protocols, diagnostic reasoning, hospital workflows and research. HEALTHx explores how to capture that knowledge, evaluate its readiness and develop responsible paths to implementation. The ambition is to grow a Saudi collaboration network spanning universities, healthcare organizations and industry.
National ambition describes the project’s intended reach; it does not denote a government mandate or an announced national program.
02 / Project status
Research is already underway.
Majed · Ongoing master’s research
Under Prof. Adeeb Noor’s supervision, Majed is working on the first stage of HEALTHx: discovering and documenting clinical knowledge. He has completed the literature review and evaluation protocol, and development began in October 2026. Technical details are shared with partners under confidentiality arrangements.
Invention disclosure under review
Invention disclosure under review. Inventive mechanisms remain confidential and are shared with partners only under a confidentiality agreement.
03 / Where you fit
One project. Five ways to move it forward.
Medical students are welcome alongside clinicians, researchers, engineers and innovation professionals. Each proposed contribution starts with a bounded question and a tangible output, agreed with the founder.
Illustrations depict research themes. Impacts are intended outcomes to evaluate. Global links are independent references, not partnerships or endorsements by the named institutions. References reviewed 3 October 2026.
01Clinical perspective
Clinicians, medical students and health researchers
Identify a real clinical need and define how a useful solution would be assessed.
Problem to address
Clinical observations can remain isolated ideas, without an agreed care problem or a meaningful outcome to test.
Value
Turn clinical experience into a clearly defined unmet need.
Intended impact
Help clinicians and patients shape solutions around real care needs.
How we could assess it
Clinician agreement on the problem, relevance of the proposed outcome and usability feedback.
Possible first output
A problem brief and a clinician-reviewed evaluation question.
Research question & global references
Proposed question
Can a structured needs-discovery method produce problems and endpoints that different clinicians consistently prioritize?
Patient-safety priorities and needs-led innovation are useful reference points for selecting the first hospital use case.
02AI & knowledge representation
AI, NLP, informatics and software contributors
Explore structured extraction and traceable representations of clinical knowledge, with human review.
Problem to address
AI-generated clinical knowledge can be difficult to trace to its source or challenge when context is missing.
Value
Make clinical knowledge structured, traceable and easier to review.
Intended impact
Support researchers and clinical reviewers in finding evidence and checking AI outputs.
How we could assess it
Extraction accuracy, source traceability and errors identified during expert review.
Possible first output
A prototype using public or synthetic examples and an error-analysis plan.
Research question & global references
Proposed question
Does source-linked extraction improve expert review compared with an unstructured AI summary?
WHO health-AI governance and UNESCO AI ethics provide reference principles for human oversight, accountability and evaluation.
03Medical protocols
Medicine, nursing, pharmacy and clinical informatics
Map a protocol’s steps, evidence, exceptions and version history into a reviewable structure.
Problem to address
Turning narrative clinical guidance into digital workflows can lose conditions, exceptions and the evidence behind a decision.
Value
Make the reasoning, exceptions and evidence behind a protocol explicit.
Intended impact
Help care teams review pathways consistently and identify gaps before testing changes.
How we could assess it
Completeness of the protocol model, reviewer agreement and coverage of exception cases.
Possible first output
An annotated protocol template using material approved for this purpose.
Research question & global references
Proposed question
How faithfully can a protocol representation preserve decision logic and exceptions across independent reviewers?
WHO SMART Guidelines address the translation of guidance into reusable digital specifications. HEALTHx proposes to use this as a methodological reference.
04Administration & governance
Health administration, operations and innovation teams
Define responsibilities, review gates and the handoffs from an idea to a pilot.
Problem to address
Innovation can stall when clinical, technical, ethical and business teams lack explicit review criteria and decision ownership.
Value
Clarify who decides, what evidence is needed and when a project can advance.
Intended impact
Help health organizations coordinate innovation with accountable decisions and clearer handoffs.
How we could assess it
Time to a documented review decision, handoff completeness and unresolved responsibilities.
Possible first output
A workflow map with decision owners and readiness criteria.
Research question & global references
Proposed question
Can explicit decision gates improve review completeness and clarify responsibility without adding unnecessary delay?
UNESCO ethics and WHO patient-safety planning offer reference points for accountable, multidisciplinary review.
05Commercialization & adoption
Health economics, business, IP and industry partners
Test who would use an innovation, what value it provides and which route to adoption is plausible.
Problem to address
A promising prototype may have no validated user need, adoption pathway or workable business model.
Value
Test whether an innovation solves a problem that users and partners value.
Intended impact
Help innovators and partners choose a credible route to adoption before committing to scale.
How we could assess it
User interviews, tested value assumptions, adoption barriers and pilot partner interest.
Possible first output
A stakeholder map and a testable adoption or value hypothesis.
Research question & global references
Proposed question
Which customer, workflow and purchasing assumptions must hold for a hospital-tested solution to be adopted elsewhere?
Mayo Clinic’s innovation exchange and Johns Hopkins’ design education illustrate connections between clinical expertise, development and commercialization.
04 / How we work
From a question to a responsible pilot.
Research design and evaluation planning are in place for the master’s work, with coding authorized on 3 October 2026. A hospital pilot, licensing and wider adoption remain proposed stages dependent on evidence, partners and approvals. No clinical validation, revenue or deployment date is claimed.
Ethics, privacy, clinical review and IP requirements are scoped for each contribution before work requiring those approvals begins.
Partner questions
What partners ask first.
Who owns the intellectual property?
HEALTHx’s background IP is managed through King Abdulaziz University’s procedures. Rights in anything developed together are agreed in writing before work begins.
Do we need to share patient data?
No patient data is needed to start. Any work with clinical data takes place inside the hospital, and only after ethics and data-governance approval.
What does a hospital commit at the start?
A clinical lead, an executive sponsor and a discovery session on one priority problem. Larger commitments are agreed later, based on what that session shows.
Can researchers outside the University take part?
Yes, in Saudi Arabia and internationally. Scope, supervision, credit and IP are agreed first.
What happens after we get in touch?
We review your message and propose a short introductory call to see whether there is a suitable use case or research question to start with.
05 / An invitation to contribute
Bring a question worth working on.
Tell us your field, the track that interests you, a problem you have observed and the time you can contribute. Students can propose a focused research question; organizations can propose a use case or a validation partnership.
Expressions of interest are reviewed to agree scope, supervision, contribution credit and IP arrangements. Participation does not automatically confer a funded position or thesis supervision. Please send a non-confidential introduction; do not include patient information or unpublished invention details.
Founder · Prof. Adeeb Noor